ストックスクリーナーアプリを入手
1.17
1.74%
0.02
アフターアワーズ：
1.21
0.04
+3.42%
Climb Bio Inc (CLYM) 最新ニュース
CLYM stock touches 52-week low at $1.2 amid market challenges - Investing.com Australia
Climb Bio expands board with two new directors By Investing.com - Investing.com Australia
Climb Bio appoints Kim Cobleigh Drapkin, Bo Cumbo to board - TipRanks
Climb Bio expands board with two new directors - Investing.com
Climb Bio Expands Board with New Director Appointments - TipRanks
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study - The Manila Times
Biotech Leaders Join Climb Bio Board: 11 Successful Drug Launches Experience - Stock Titan
CLYM stock touches 52-week low at $1.2 amid market challenges By Investing.com - Investing.com South Africa
What is Leerink Partnrs’ Estimate for Climb Bio Q2 Earnings? - Defense World
Bioplastics And Biopolymers Market Key Drivers, Opportunities and Trends | Exactitude Consultancy - Yahoo Finance
Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Healthcare Spotlight: Climb Bio Takes Center Stage at Major Needham Conference - Stock Titan
Climb Bio Advances Clinical Trials and Expands Pipeline - TipRanks
Can you use home equity to pay for long-term care? - Yahoo Finance
Climb Bio Fueled Up with Cash, Poised for More Milestones in ’25 – Quarterly Update Report - Yahoo Finance
Climb Bio Fueled Up with Cash, Poised for More Milestones in ’25 – Downloadable Quarterly Update - Yahoo Finance
Citigroup (C) Could Be a Great Choice - Yahoo Finance
China deals look beyond cancer - BioCentury
Climb Bio Files For Offering Of Common Stock Up To $22.4 MillionSEC Filing - MarketScreener
Climb Bio Reports Fourth Quarter And Year-End 2024 Financial Results And Provides Business Updates - Marketscreener.com
Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates - Yahoo
Conagra to close Michigan plant, impacting 85 jobs - Yahoo Finance
Exclusive: BlackRock expands blockchain-based money market to Solana, in tie-up with startup Securitize - Yahoo Finance
Climb Bio Secures 3-Year Cash Runway with $212M, Advances Multi-Disease Pipeline - Stock Titan
Climb bio SVP Emily Pimblett sells shares worth $1,570 By Investing.com - Investing.com South Africa
Climb bio SVP Emily Pimblett sells shares worth $1,570 - Investing.com India
Why Are Jabil (JBL) Shares Soaring Today - Yahoo Finance
Climb Bio: Meet The Newest Star in Autoimmune Disease Treatment – Initiation Report - Yahoo Finance
Climb Bio (CLYM) Expected to Announce Earnings on Thursday - Defense World
Gossamer Bio shares rise on Q4 earnings beat By Investing.com - Investing.com South Africa
Gossamer Bio shares rise on Q4 earnings beat - Investing.com India
Bio-Key International Inc (BKYI): Major Improvements, Worth A Look - Stocks Register
Sugar Prices Climb on the Prospects for Lower Global Sugar Production - The Globe and Mail
Sugar Prices Climb on the Outlook for Small Sugar Output in India - The Globe and Mail
CLYM stock touches 52-week low at $1.29 amid market challenges - Investing.com Australia
CLYM stock touches 52-week low at $1.29 amid market challenges By Investing.com - Investing.com South Africa
(PDF) Research on Dynamics and Stability in the Stairs-Climbing of a Tracked Mobile Robot - ResearchGate
Stocks of Codexis Inc (CDXS) are poised to climb above their peers - SETE News
Mineralys shares climb on study data for blood pressure drug - BioPharma Dive
First-class stamp price climbs to £1.70 in ‘blow to consumers’ - Yahoo Finance UK
Global stocks climb as pound and euro hit four-month high against US dollar - Yahoo Finance UK
Climb Bio (NASDAQ:CLYM) Shares Down 6.9% – Should You Sell? - Defense World
FTSE 100 and US stocks climb higher as US inflation report meets expectations - Yahoo Finance UK
Stocks Climb Ahead Of Nvidia's Earnings Results - Barchart
Coupang’s shares climb after profit surges in competitive market - Fortune
CLYM stock touches 52-week low at $1.4 amid market challenges - Investing.com Australia
CLYM stock touches 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa
Plug To Announce 2024 Fourth Quarter and Year-End Results - The Manila Times
Climb Bio to Present at Upcoming Investor Conferences - The Bakersfield Californian
Climb Bio Sets Investor Calendar: Key March Presentations at Major Healthcare Conferences - StockTitan
Climb Bio appoints new Chief Business Officer By Investing.com - Investing.com Australia
Climb Bio appoints new Chief Business Officer - Investing.com India
10.70%
大文字化:
|
ボリューム (24 時間):